PIAS3 and plasma cell myeloma: In fact, several miRs, including miR‐18a, have been reported to regulate PIAS3 expression in other diseases, including gastric cancer, multiple myeloma, and chronic lymphocytic leukemia (Brock et al., 2011; Carabia et al., 2017; Huang et al., 2016; Pitari et al., 2015; Wang et al., 2017; Wu et al., 2013; Xiong et al., 2012).